Status:
COMPLETED
Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246)
Lead Sponsor:
Organon and Co
Conditions:
Perennial Allergic Rhinitis
Eligibility:
All Genders
15-85 years
Phase:
PHASE3
Brief Summary
This study will assess the ability of montelukast to improve the signs and symptoms of perennial allergic rhinitis compared to placebo. Cetirizine is included in the study as an active control.
Eligibility Criteria
Inclusion
- Patient has a documented clinical history of perennial allergic rhinitis
- Patient is a nonsmoker
- Patient is in good general health
Exclusion
- Patient is hospitalized
- Patient is a woman who is \<8 weeks postpartum or is breast-feeding
- Patient is a current or past abuser of alcohol or illicit drugs
Key Trial Info
Start Date :
November 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2002
Estimated Enrollment :
1365 Patients enrolled
Trial Details
Trial ID
NCT00974571
Start Date
November 1 2001
End Date
May 1 2002
Last Update
February 3 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.